Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review
- PMID: 16025188
- DOI: 10.1007/s00192-005-1357-7
Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review
Abstract
This systematic review examined the use of incontinence-specific quality of life (QOL) measures in clinical trials of female incontinence treatments, and systematically evaluated their quality using a standard checklist. Of 61 trials included in the review, 58 (95.1%) used an incontinence-specific QOL measure. The most commonly used were IIQ (19 papers), I-QoL (12 papers) and UDI (9 papers). Eleven papers (18.0%) used measures which were not referenced or were developed specifically for the study. The eight QOL measures identified had good clinical face validity and measurement properties. We advise researchers to evaluate carefully the needs of their specific study, and select the QOL measure that is most appropriate in terms of validity, utility and relevance, and discourage the development of new measures. Until better evidence is available on the validity and comparability of measures, we recommend that researchers consider using IIQ or I-QOL with or without UDI in trials of incontinence treatments.
Similar articles
-
Acupuncture for treating overactive bladder in adults.Cochrane Database Syst Rev. 2022 Sep 23;9(9):CD013519. doi: 10.1002/14651858.CD013519.pub2. Cochrane Database Syst Rev. 2022. PMID: 36148895 Free PMC article.
-
Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews.Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD012337. doi: 10.1002/14651858.CD012337.pub2. Cochrane Database Syst Rev. 2022. PMID: 36053030 Free PMC article.
-
Systematic review and evaluation of methods of assessing urinary incontinence.Health Technol Assess. 2006 Feb;10(6):1-132, iii-iv. doi: 10.3310/hta10060. Health Technol Assess. 2006. PMID: 16487456
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.Cochrane Database Syst Rev. 2018 Aug 19;8(8):CD013108. doi: 10.1002/14651858.CD013108. Cochrane Database Syst Rev. 2018. PMID: 30121956 Free PMC article.
Cited by
-
What is the predictive value of urodynamics to reproduce clinical findings of urinary frequency, urge urinary incontinence, and/or stress urinary incontinence?Int Urogynecol J. 2010 Oct;21(10):1205-9. doi: 10.1007/s00192-010-1180-7. Epub 2010 Jun 18. Int Urogynecol J. 2010. PMID: 20559620
-
Clinical characteristics of women with familial pelvic floor disorders.Int Urogynecol J. 2015 Mar;26(3):401-6. doi: 10.1007/s00192-014-2513-8. Epub 2014 Oct 29. Int Urogynecol J. 2015. PMID: 25352072
-
Trans-obturator surgery for stress urinary incontinence: 1-year follow-up of a cohort of 52 women.Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jan;18(1):27-32. doi: 10.1007/s00192-006-0115-9. Epub 2006 Mar 31. Int Urogynecol J Pelvic Floor Dysfunct. 2007. PMID: 16575486
-
Incontinence-specific quality of life measures used in trials of sling procedures for female stress urinary incontinence: a meta-analysis.Int Urol Nephrol. 2015 Aug;47(8):1277-95. doi: 10.1007/s11255-015-1020-2. Epub 2015 Jun 21. Int Urol Nephrol. 2015. PMID: 26093584 Review.
-
Self-reported pad use per day reflects patient quality of life after pubovaginal sling surgery.Int Urogynecol J Pelvic Floor Dysfunct. 2009 Nov;20(11):1321-5. doi: 10.1007/s00192-009-0939-1. Epub 2009 Jul 1. Int Urogynecol J Pelvic Floor Dysfunct. 2009. PMID: 19568684
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical